Department of Pharmaceutical Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Obes Surg. 2010 Feb;20(2):204-10. doi: 10.1007/s11695-009-0041-2. Epub 2009 Dec 8.
It is believed that endothelial dysfunction associated with obesity contributes to reduced vascular production of nitric oxide (NO). Weight reduction after bariatric surgery is known to decrease the risk of cardiovascular disease. The purpose of this study was to determine whether bariatric surgery leads to improvement of metabolic markers of endothelial function: serum NO and its precursor (arginine) concentrations in obese patients.
Serum NO and L-arginine concentrations were measured in 25 morbidly obese patients directly before and 6 months after bariatric surgery. Moreover, selected parameters that may be involved in development of endothelial dysfunction were also studied. Control group consisted of ten healthy individuals with normal body weight.
Six months after bariatric surgery, serum NO concentration was approximately 40% higher than before surgery. Surprisingly, serum NO concentration in nonobese controls was essentially similar to obese patients before surgery. In contrast, serum L-arginine concentration was higher in obese patients than in controls and decreased significantly after surgery. The body weight, blood pressure, triacylglycerols, LDL/HDL-cholesterol ratio, insulin, homeostasis model assessment score (HOMA-index), C-reactive protein, and white blood cell count were higher in obese patients as compared with controls and decreased significantly after surgery.
Our results indicate that improvement of insulin resistance, lipidemia, and blood pressure as well as reduction of systemic inflammation after bariatric surgery were associated with the increase of serum NO concentration. We propose that the increase in serum NO concentration contribute to diverse beneficial effects of weight loss after bariatric surgery especially in the context of risk of atherosclerosis.
据信与肥胖相关的内皮功能障碍会导致血管中一氧化氮 (NO) 的产生减少。减重手术(bariatric surgery)后体重减轻已知会降低心血管疾病的风险。本研究的目的是确定减重手术是否会改善肥胖患者内皮功能的代谢标志物:血清 NO 及其前体(精氨酸)浓度。
在 25 名病态肥胖患者进行减重手术之前和之后 6 个月直接测量血清 NO 和 L-精氨酸浓度。此外,还研究了可能涉及内皮功能障碍发展的选定参数。对照组由 10 名体重正常的健康个体组成。
减重手术后 6 个月,血清 NO 浓度比手术前高约 40%。令人惊讶的是,非肥胖对照组的血清 NO 浓度与手术前肥胖患者基本相似。相比之下,血清 L-精氨酸浓度在肥胖患者中高于对照组,手术后显著下降。与对照组相比,肥胖患者的体重、血压、三酰甘油、LDL/HDL-胆固醇比值、胰岛素、稳态模型评估评分(HOMA 指数)、C 反应蛋白和白细胞计数更高,手术后显著下降。
我们的结果表明,减重手术后胰岛素抵抗、血脂异常和血压改善以及全身炎症减轻与血清 NO 浓度升高有关。我们提出,血清 NO 浓度的升高有助于减重手术后的多种有益效应,尤其是在动脉粥样硬化风险的背景下。